Cargando…
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia
Thiamine-responsive megaloblastic anaemia (TRMA) is a syndrome associated with megaloblastic anaemia, diabetes mellitus and sensorineural deafness, due to mutations in the SLC19A2gene, which codes for a thiamine carrier protein. Oral thiamine supplementation is the main treatment. We report the case...
Autores principales: | Nouira, Nourelhouda, Mansouri, Rawdha, Tlili, Rami, Bhouri, Ines, Sfaxi, Souha, Chtourou, Dorra, cheikh, Maamoun Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608766/ https://www.ncbi.nlm.nih.gov/pubmed/33193954 http://dx.doi.org/10.11604/pamj.supp.2020.35.139.25368 |
Ejemplares similares
-
Does Early Treatment Prevent Deafness in Thiamine-Responsive Megaloblastic Anaemia Syndrome?
por: Akın, Leyla, et al.
Publicado: (2011) -
Megaloblastic Anæmia of Pregnancy and the Puerperium
por: Clark, James R.
Publicado: (1952) -
Cochlear implant and thiamine-responsive megaloblastic anemia syndrome
por: Hagr, Abdulrahman Abdullah
Publicado: (2014) -
Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
por: Faraji‐Goodarzi, Mojgan, et al.
Publicado: (2020) -
Stroke as an Initial Manifestation of Thiamine-Responsive Megaloblastic Anemia
por: Madaan, Priyanka, et al.
Publicado: (2020)